Isradipine |
DynaCirc |
Article: Isradipine
| Image:Isradipine.png | |
| Isradipine | |
| Systematic (IUPAC) name | |
| methyl propan-2-yl 2,6-dimethyl-4- (8-oxa-7,9-diazabicyclo[4.3.0] nona- 2,4,6,9- tetraen- 5-yl)- 1,4-dihydropyridine- 3,5-dicarboxylate | |
| Identifiers | |
| CAS number | 75695-93-1 |
| ATC code | C08CA03 |
| PubChem | 3784 |
| DrugBank | APRD00298 |
| Chemical data | |
| Formula | C19H21N3O5 |
| Mol. weight | 371.387 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 95% |
| Metabolism | ? |
| Half life | 8 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Isradipine is a calcium channel blocker of the dihydropyridine class.
Resources
- DynaCirc (Drug Digest)
- Isradipine (Drug Digest)

Not Signed In -


